WHA announces new CEO and President-elect
Cary James has been selected as
WHA’s new CEO and will begin in
April. Dr. Su Wang, who previously
served as Executive Board
Member for the PAHO region, has
been appointed President-Elect. and successful campaigns and collaborated
with numerous civil society organisations
during his time as a member of the leadership
team at the UK’s Terrence Higgins Trust. He
has been a member of international advisory
panels and expert groups on diagnostics, digital
communications, health equality, HIV, hepatitis,
tuberculosis and sexual health.
Cary brings decades of experience in public
health programmes and health policy at
the national and international levels. He is
a recognised leader in putting patients and
communities at the centre of policy and
programmes. “Cary has a proven record of working closely
with governmental and non-governmental
organisations to tailor programmes to unique
populations as well as high-level engagement
with the WHO and UN, which are important
skills in the work of the Alliance,” said Michael
Ninburg, president of WHA.
“I am excited for this opportunity to use
my skills and experience to champion our
members and people affected by viral hepatitis
to make viral hepatitis elimination a reality,”
Cary said.
Cary has worked extensively in hepatitis and
HIV response, having developed innovative
“I am delighted to be passing on the torch to
Cary who will be a great fit to the organisation
and an exciting appointment to drive the
Alliance forward,” added Raquel Peck, senior
advisor and former CEO of World Hepatitis
Alliance.
New WHA CEO Cary James (left) with WHA President,
Michael Ninburg, and new President-elect, Dr. Su Wang
6 hep Voice MARCH 2019
Dr. Su Wang has
been appointed
WHA President-
Elect, having
served on the
executive board
of the WHA since
2014 as a regional
representative
for the PAHO
region. Su is an
internal medicine
physician who
discovered she
had hepatitis B
after donating
blood in college
WHA President, Michael Ninburg, with new President-elect Dr. Su Wang
and has used her own personal experience
to advocate for the elimination of hepatitis.
She worked for many years in New York
City leading outreach and care programmes
for hepatitis B patients, and now directs a
number of hepatitis B and C programmes in
her current role as Medical Director for the
Center for Asian Health at Saint Barnabas
Medical Center in New Jersey.
“Su has a long history of championing
hepatitis B care in underserved populations
and has been a strong advocate of expanding
hepatitis B and C services to frontline
providers. She is a well-respected leader in
the field and has also been an integral part
of developing our NOhep Medical Visionaries
programme. She is also a good friend.” said
Michael Ninburg.
Dr. Wang added, “I am honoured to have
this opportunity to serve as President and
continue the great work of the Alliance in
moving us towards elimination by 2030.”
As President-Elect, she will shadow current
President Michael Ninburg until January 2020,
when she will take up the role of President.
“I am thrilled with this next generation
of leadership at the Alliance. We are well
positioned for the next chapter in the race to
eliminate viral hepatitis” said WHA President
Michael Ninburg.
Click here to find out more about WHA’s
new CEO and President-Elect, and to watch
Michael, Cary and Su discuss the new
appointments.
hep Voice
MARCH 2019 7